Leigh C. Maier

Array ( [id] => 12808540 [patent_doc_number] => 20180161350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-14 [patent_title] => TERNARY MIXTURES OF 6'-SL, LNnT and LST c [patent_app_type] => utility [patent_app_number] => 15/579818 [patent_app_country] => US [patent_app_date] => 2016-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9366 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15579818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12813361 [patent_doc_number] => 20180162957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-14 [patent_title] => PROCESS FOR PREPARING (1→6)-α-D-GLUCAN [patent_app_type] => utility [patent_app_number] => 15/503576 [patent_app_country] => US [patent_app_date] => 2016-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1381 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11602430 [patent_doc_number] => 20170119730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-04 [patent_title] => 'Combination Therapy for Effecting Weight Loss and Treating Obesity' [patent_app_type] => utility [patent_app_number] => 15/172448 [patent_app_country] => US [patent_app_date] => 2016-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8967 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15172448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13328605 [patent_doc_number] => 20180215840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-02 [patent_title] => COMBINATION OF CROSS-LINKED HYALURONIC ACIDS AND METHOD OF PREPARING THE SAME [patent_app_type] => utility [patent_app_number] => 15/322326 [patent_app_country] => US [patent_app_date] => 2016-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7340 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15322326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12746383 [patent_doc_number] => 20180140628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-24 [patent_title] => COMPOSITION INCLUDING GLYCOSAMINOGLYCAN DERIVATIVE AND CHEMOKINE RECEPTOR ACTIVITY REGULATOR [patent_app_type] => utility [patent_app_number] => 15/578034 [patent_app_country] => US [patent_app_date] => 2016-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16841 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15578034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12728932 [patent_doc_number] => 20180134811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-17 [patent_title] => CELLULOSE ETHER POWDERS [patent_app_type] => utility [patent_app_number] => 15/574496 [patent_app_country] => US [patent_app_date] => 2016-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6446 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15574496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11053282 [patent_doc_number] => 20160250244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-01 [patent_title] => 'COMPOSITIONS FOR TREATING HEARTWORM INFESTATION' [patent_app_type] => utility [patent_app_number] => 15/150502 [patent_app_country] => US [patent_app_date] => 2016-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4926 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15150502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11046131 [patent_doc_number] => 20160243089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-25 [patent_title] => 'FORAZOLINES, COMPOSITIONS THEREOF AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/146672 [patent_app_country] => US [patent_app_date] => 2016-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7072 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15146672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12238464 [patent_doc_number] => 20180071327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-15 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING GLEEVEC-RESISTANT LEUKEMIA CONTAINING GINSENOSIDE F1 OR GINSENOSIDE RG3 AS AN ACTIVE INGREDIENT' [patent_app_type] => utility [patent_app_number] => 15/511637 [patent_app_country] => US [patent_app_date] => 2016-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5547 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15511637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11046197 [patent_doc_number] => 20160243155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-25 [patent_title] => 'COMPOSITION FOR BODY FAT CONSUMPTION' [patent_app_type] => utility [patent_app_number] => 15/142282 [patent_app_country] => US [patent_app_date] => 2016-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3891 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15142282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12786238 [patent_doc_number] => 20180153915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-07 [patent_title] => USE OF OLIGOSACCHARIDE COMPOSITIONS TO ENHANCE WEIGHT GAIN [patent_app_type] => utility [patent_app_number] => 15/569993 [patent_app_country] => US [patent_app_date] => 2016-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24216 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11561743 [patent_doc_number] => 09624314 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-18 [patent_title] => 'Porous cyclodextrin polymeric materials and methods of making and using same' [patent_app_type] => utility [patent_app_number] => 15/134030 [patent_app_country] => US [patent_app_date] => 2016-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 71 [patent_figures_cnt] => 98 [patent_no_of_words] => 22851 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15134030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12580689 [patent_doc_number] => 20180085392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-29 [patent_title] => CYCLODEXTRIN COMPOUNDS FOR THE PREVENTION AND TREATMENT OF AGING [patent_app_type] => utility [patent_app_number] => 15/567121 [patent_app_country] => US [patent_app_date] => 2016-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8704 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15567121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11092378 [patent_doc_number] => 20160289345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-06 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 15/088819 [patent_app_country] => US [patent_app_date] => 2016-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10402 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15088819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10996407 [patent_doc_number] => 20160193353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-07 [patent_title] => 'FACTOR VIII: REMODELING AND GLYCOCONJUGATION OF FACTOR VIII' [patent_app_type] => utility [patent_app_number] => 15/072044 [patent_app_country] => US [patent_app_date] => 2016-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 497 [patent_figures_cnt] => 497 [patent_no_of_words] => 152167 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15072044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10988937 [patent_doc_number] => 20160185881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-30 [patent_title] => 'Oligosaccharide Compounds' [patent_app_type] => utility [patent_app_number] => 15/063272 [patent_app_country] => US [patent_app_date] => 2016-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 62685 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15063272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14791475 [patent_doc_number] => 10398723 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2019-09-03 [patent_title] => Hyaluronan-containing composition and use thereof for mitigation and/or prevention of inflammation and/or pain [patent_app_type] => utility [patent_app_number] => 15/051033 [patent_app_country] => US [patent_app_date] => 2016-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17795 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15051033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13368895 [patent_doc_number] => 20180235988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-23 [patent_title] => SIALYLATION-INCREASING THERAPIES FOR DISEASES ASSOCIATED WITH OXIDATIVE STRESS [patent_app_type] => utility [patent_app_number] => 15/553561 [patent_app_country] => US [patent_app_date] => 2016-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22157 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15553561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11046186 [patent_doc_number] => 20160243144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-25 [patent_title] => 'FIXED DOSE COMBINATION FORMULATIONS OF RIFAXIMIN AND LACTULOSE' [patent_app_type] => utility [patent_app_number] => 15/049293 [patent_app_country] => US [patent_app_date] => 2016-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10057 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15049293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11038823 [patent_doc_number] => 20160235779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-18 [patent_title] => 'TREATMENT OF CANCERS AND HEMATOPOIETIC STEM CELL DISORDERS PRIVILEGED BY CXCL12-CXCR4 INTERACTION' [patent_app_type] => utility [patent_app_number] => 15/044740 [patent_app_country] => US [patent_app_date] => 2016-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19740 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15044740 [rel_patent_id] =>[rel_patent_doc_number] =>)